Susquehanna International Group, LLP Beam Therapeutics Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$22.57 - $33.14 $2.98 Million - $4.38 Million	132,200 Added 143.07%	224,600 $5.5 Million
Q2 2024 Aug 15, 2024	SELL	$21.22 - $32.66 $218,566 - $336,397	-10,300 Reduced 10.03%	92,400 $2.16 Million
Q1 2024 May 07, 2024	SELL	$23.46 - $45.07 $715,530 - $1.37 Million	-30,500 Reduced 22.9%	102,700 $3.39 Million
Q4 2023 Feb 14, 2024	BUY	$17.69 - $30.76 $1.09 Million - $1.89 Million	61,400 Added 85.52%	133,200 $3.63 Million
Q3 2023 Nov 14, 2023	SELL	$23.01 - $32.46 $2.72 Million - $3.83 Million	-118,000 Reduced 62.17%	71,800 $1.73 Million
Q2 2023 Aug 11, 2023	BUY	$29.32 - $35.99 $2.7 Million - $3.31 Million	92,100 Added 94.27%	189,800 $6.06 Million
Q1 2023 May 16, 2023	BUY	$30.15 - $48.79 $1.25 Million - $2.02 Million	41,500 Added 73.84%	97,700 $2.99 Million
Q4 2022 Feb 14, 2023	SELL	$36.73 - $51.6 $12.3 Million - $17.3 Million	-334,900 Reduced 85.63%	56,200 $2.2 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $9.07 Million - $16 Million	227,900 Added 139.64%	391,100 $18.6 Million
Q2 2022 Aug 15, 2022	BUY	$29.86 - $62.36 $1 Million - $2.09 Million	33,500 Added 25.83%	163,200 $6.32 Million
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $2.75 Million - $4.2 Million	51,100 Added 65.01%	129,700 $7.43 Million
Q4 2021 Feb 14, 2022	SELL	$68.02 - $99.06 $1.35 Million - $1.96 Million	-19,800 Reduced 20.12%	78,600 $6.26 Million
Q3 2021 Nov 15, 2021	SELL	$84.37 - $133.6 $4.44 Million - $7.03 Million	-52,600 Reduced 34.83%	98,400 $8.56 Million
Q2 2021 Aug 11, 2021	SELL	$64.12 - $128.71 $9.93 Million - $19.9 Million	-154,800 Reduced 50.62%	151,000 $19.4 Million
Q1 2021 May 17, 2021	BUY	$71.28 - $120.75 $14.2 Million - $24.1 Million	199,500 Added 187.68%	305,800 $24.5 Million
Q4 2020 Feb 16, 2021	BUY	$22.24 - $95.63 $2.36 Million - $10.2 Million	106,300 New	106,300 $8.68 Million

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

Farallon Capital Management LLC San Francisco, CA

8.21M
Shares

$197 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.84M
Shares

$189 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.63M
Shares

$184 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

6.53M
Shares

$157 Million
1.52% of portfolio
Arch Venture Management, LLC Chicago, IL

4.83M
Shares

$116 Million
71.21% of portfolio

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.69B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account